Ars Pharms Operation Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ARS PHARMS OPERATION, and when can generic versions of ARS PHARMS OPERATION drugs launch?
ARS PHARMS OPERATION has one approved drug.
There are seven US patents protecting ARS PHARMS OPERATION drugs.
There are sixty-four patent family members on ARS PHARMS OPERATION drugs in twenty-eight countries.
Summary for Ars Pharms Operation
| International Patents: | 64 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ars Pharms Operation
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 10,682,414 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 11,744,895 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 11,717,571 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
